retatrutide stomach issues Unapproved weight loss drug causes extreme side effects What Does Retatrutide Do?
Description
10.1016/j.bbrc.2019.01.103 Summary Keywords heart failure, cognitive impairment, type 2 diabetes, glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors Citation Riemma MA, Mele E, Donniacuo M, Telesca M, Bellocchio G, Castaldo G, Rossi F, De Angelis A, Cappetta D, Urbanek K and Berrino L (2024) Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
The N-terminal Phe residue in GEP12 likely contributes to its increased affinity for the extracellular binding domain of GLP-1R
[CrossRef] [PubMed] [Google Scholar] Diabetes and epilepsy in children and adolescents
WHO, 2023
